Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune response.
PMID 41735308 · PMC13043769 · Nature communications · 2026 · 8 claims · 8 setups
OSGEP is the catalytic subunit of the KEOPS complex responsible for t6A modification at position 37 of cytoplasmic tRNAs, and its loss causes the highest protein aggregation among 45 screened tRNA-modifying enzymes in melanoma cells
-
Full-text index only
Sequential transcriptional waves and NF-κB-driven chromatin remodeling direct drug-induced dedifferentiation in cancer.
PMID 41986344 · PMC13083995 · Nature communications · 2026 · 8 claims · 8 setups
BRAFi (vemurafenib) treatment drives BRAF-mutant melanoma cells through a reversible dedifferentiation transition from a melanocytic state through a neural crest-like state to a drug-tolerant mesenchymal state
-
Has reproduction · 88
An engineered tumor organoid model reveals cellular identity and signaling trajectories underlying SFPQ-TFE3 driven translocation RCC.
PMID 40463960 · PMC12131257 · iScience · 2025 · 8 claims · 7 setups
SFPQ-TFE3 expression is sufficient to transform normal kidney epithelial tubuloids into tRCC
-
Full-text index only
Emergence of oncofetal plasticity is ubiquitous in early colorectal cancers.
PMID 41986711 · PMC13233332 · Nature · 2026 · 8 claims · 7 setups
Metastasis-associated oncofetal cell states emerge already at the earliest stages of colorectal cancer, concurrent with invasive front formation
-
Full-text index only
Systematic design of combination therapy by targeting master regulators of coexisting diffuse midline glioma cell states.
PMID 42020604 · PMC13175895 · Nature genetics · 2026 · 8 claims · 6 setups
A generalizable, network-based framework was established to systematically identify combination therapies targeting complementary coexisting tumor cell states